CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIENCY - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance (in shares)			155,978,020
Beginning Balance	$ (739,064)	$ (805,772)	$ (741,814)	$ (807,877)
Net income	54,178	38,089	88,978	72,830
Total other comprehensive income	125	161	114	370
Dividends on common stock	(31,940)	(31,755)	(63,888)	(63,519)
Restricted stock grants			0	0
Withholding of shares as payment of payroll tax liabilities in connection with restricted stock vesting	(452)	(493)	(3,857)	(3,152)
Withholding of shares as payment of payroll tax liabilities in connection with exercise of stock options				(12,633)
Exercise of stock options				12,105
Stock-based compensation	$ 3,807	2,645	$ 7,121	4,751
Ending Balance (in shares)	157,377,564		157,377,564
Ending Balance	$ (713,346)	$ (797,125)	$ (713,346)	$ (797,125)
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance (in shares)	157,419,093	155,976,547	155,978,020	154,840,902
Beginning Balance	$ 15,742	$ 15,598	$ 15,598	$ 15,484
Restricted stock grants (in shares)			1,745,000	1,290,000
Restricted stock grants			$ 175	$ 129
Withholding of shares as payment of payroll tax liabilities in connection with restricted stock vesting (in shares)	(41,529)	(41,560)	(345,456)	(238,981)
Withholding of shares as payment of payroll tax liabilities in connection with restricted stock vesting	$ (4)	$ (5)	$ (35)	$ (25)
Withholding of shares as payment of payroll tax liabilities in connection with exercise of stock options (in shares)				(1,012,249)
Withholding of shares as payment of payroll tax liabilities in connection with exercise of stock options				$ (101)
Exercise of stock options (in shares)				1,055,315
Exercise of stock options				$ 106
Ending Balance (in shares)	157,377,564	155,934,987	157,377,564	155,934,987
Ending Balance	$ 15,738	$ 15,593	$ 15,738	$ 15,593
Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	11,149	3,897	11,384	5,092
Restricted stock grants			(175)	(129)
Withholding of shares as payment of payroll tax liabilities in connection with restricted stock vesting	(448)	(488)	(3,822)	(3,127)
Withholding of shares as payment of payroll tax liabilities in connection with exercise of stock options				(12,532)
Exercise of stock options				11,999
Stock-based compensation	3,807	2,645	7,121	4,751
Ending Balance	14,508	6,054	14,508	6,054
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	(753,031)	(809,403)	(755,883)	(812,380)
Net income	54,178	38,089	88,978	72,830
Dividends on common stock	(31,940)	(31,755)	(63,888)	(63,519)
Ending Balance	(730,793)	(803,069)	(730,793)	(803,069)
Accumulated Other Comprehensive Loss
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	(12,924)	(15,864)	(12,913)	(16,073)
Total other comprehensive income	125	161	114	370
Ending Balance	$ (12,799)	$ (15,703)	$ (12,799)	$ (15,703)